TEACHERS ADVISORS, LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 79 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2019$1,098,000
+82.1%
154,802
+24.7%
0.00%0.0%
Q4 2018$603,000
-68.3%
124,143
-52.0%
0.00%0.0%
Q3 2018$1,900,000
+132.3%
258,442
+101.6%
0.00%0.0%
Q2 2018$818,000
+20.5%
128,199
+2.7%
0.00%0.0%
Q1 2018$679,000
+30.1%
124,775
-0.4%
0.00%0.0%
Q4 2017$522,000
-51.8%
125,245
+11.3%
0.00%0.0%
Q3 2017$1,084,000
-15.8%
112,532
+3.5%
0.00%
-50.0%
Q2 2017$1,287,000
-9.6%
108,775
-2.1%
0.00%0.0%
Q1 2017$1,424,000
+18.5%
111,084
+13.1%
0.00%0.0%
Q4 2016$1,202,000
+10.1%
98,220
+6.1%
0.00%0.0%
Q3 2016$1,092,000
+35.8%
92,568
+0.2%
0.00%
+100.0%
Q2 2016$804,000
+65.1%
92,3740.0%0.00%0.0%
Q1 2016$487,000
-32.1%
92,3740.0%0.00%0.0%
Q4 2015$717,000
+24.3%
92,374
+26.1%
0.00%0.0%
Q3 2015$577,000
-11.5%
73,255
+1.8%
0.00%0.0%
Q2 2015$652,000
-18.3%
71,986
+17.1%
0.00%0.0%
Q1 2015$798,000
-4.7%
61,4750.0%0.00%
-50.0%
Q4 2014$837,000
+51.9%
61,4750.0%0.00%
+100.0%
Q3 2014$551,000
-33.8%
61,4750.0%0.00%
-50.0%
Q2 2014$832,000
+41.0%
61,475
+3.5%
0.00%
+100.0%
Q1 2014$590,000
-12.2%
59,381
+17.7%
0.00%
-50.0%
Q4 2013$672,000
+33.9%
50,466
+22.2%
0.00%
+100.0%
Q3 2013$502,000
+25.2%
41,306
+6.4%
0.00%0.0%
Q2 2013$401,00038,8210.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Casdin Capital, LLC 2,730,000$11,384,0002.77%
CADIAN CAPITAL MANAGEMENT, LP 5,017,483$20,923,0001.28%
Ghost Tree Capital, LLC 500,000$2,085,0000.49%
Bellevue Group AG 773,677$3,226,0000.34%
NEEDHAM INVESTMENT MANAGEMENT LLC 180,000$750,0000.20%
Penn Capital Management Company, LLC 543,715$2,267,0000.16%
HighTower Advisors, LLC 2,355,942$9,826,0000.08%
Granite Investment Partners, LLC 215,760$900,0000.06%
WRAPMANAGER INC 39,547$165,0000.05%
Alyeska Investment Group, L.P. 1,563,881$6,521,0000.05%
View complete list of GENMARK DIAGNOSTICS INC shareholders